Advanced Biomed Sells Hong Kong Subsidiary for $23,000.

martes, 30 de diciembre de 2025, 10:25 am ET1 min de lectura
ADVB--

Advanced Biomed Inc. has entered into an agreement to sell 100% of its Hong Kong subsidiary for an aggregate purchase price of $23,000. The sale is subject to the terms and conditions outlined in the agreement. The intellectual property owned by the Hong Kong subsidiary, including that of its wholly-owned subsidiary Shanghai Sglcell Biotech Co., Ltd., will also be transferred as part of the sale.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios